A detailed history of Geode Capital Management, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,296,156 shares of TNYA stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,296,156
Previous 1,229,188 5.45%
Holding current value
$2.55 Million
Previous $3.81 Million 34.36%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.93 - $3.99 $129,248 - $267,202
66,968 Added 5.45%
1,296,156 $2.5 Million
Q2 2024

Aug 09, 2024

BUY
$2.72 - $4.99 $514,466 - $943,818
189,142 Added 18.19%
1,229,188 $3.81 Million
Q1 2024

May 13, 2024

BUY
$2.88 - $6.8 $320,495 - $756,724
111,283 Added 11.98%
1,040,046 $5.44 Million
Q4 2023

Feb 13, 2024

BUY
$1.73 - $3.39 $96,101 - $188,314
55,550 Added 6.36%
928,763 $3.01 Million
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.65 $136,784 - $303,071
53,641 Added 6.55%
873,213 $2.23 Million
Q2 2023

Aug 11, 2023

BUY
$2.64 - $7.64 $75,984 - $219,894
28,782 Added 3.64%
819,572 $4.81 Million
Q1 2023

May 15, 2023

BUY
$1.92 - $3.59 $604,888 - $1.13 Million
315,046 Added 66.22%
790,790 $2.25 Million
Q4 2022

Feb 13, 2023

BUY
$1.68 - $3.19 $43,404 - $82,416
25,836 Added 5.74%
475,744 $956,000
Q3 2022

Nov 14, 2022

BUY
$2.9 - $5.88 $200,874 - $407,289
69,267 Added 18.2%
449,908 $1.3 Million
Q2 2022

Aug 12, 2022

BUY
$5.01 - $14.12 $62,244 - $175,426
12,424 Added 3.37%
380,641 $2.14 Million
Q1 2022

May 13, 2022

BUY
$9.41 - $19.3 $1.31 Million - $2.68 Million
139,078 Added 60.7%
368,217 $4.34 Million
Q4 2021

Feb 11, 2022

BUY
$18.41 - $29.58 $242,570 - $389,746
13,176 Added 6.1%
229,139 $4.34 Million
Q3 2021

Nov 12, 2021

BUY
$15.35 - $26.66 $3.32 Million - $5.76 Million
215,963 New
215,963 $4.46 Million

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $81.5M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.